Development and Application of Single-use Products Is Expanding Throughout Industry

There is no denying the growing usage of disposables—only three percent of biopharmaceutical manufacturers claim to use none, according to a report by BioPlan Associates. Frost & Sullivan opines that biologics manufacturing is expected to reach 3.6 million liters in 2011. Although disposables are not entirely replacing stainless steel systems, they are being utilized for process development and in pilot plants to speed commercialization. In addition, companies are developing and/or optimizing disposables for new markets and applications.

One of the companies that offers a disposable format for down stream processing by use of the Simulated Moving Bed technology is Tarpon Biosystems. Read the full article on the web (author Nina Flanagan, published in Genetic Engineering & biotechnology News Sep 15 2007 (Vol. 27, No. 16)).